Advertisement

Topics

Immune Design Corp. Company Profile

14:21 EDT 26th March 2019 | BioPortfolio

Immune Design is a clinical-stage immunotherapy company employing next-generation in vivo approaches to enable the body’s immune system to fight disease. The company’s technologies are engineered to activate the immune system’s natural ability to create and/or expand antigen-specific cytotoxic T cells, while enhancing other immune effectors, to fight cancer and other chronic diseases. Immune Design’s three ongoing immuno-oncology clinical programs are the product of its two synergistic discovery platforms, ZVex™ and GLAAS™. Immune Design has offices in Seattle and South San Francisco. For more information, visit www.immunedesign.com.


News Articles [1116 Associated News Articles listed on BioPortfolio]

Merck acquires Immune Design for $283mm

Merck & Co. Inc. will pay $283mm to acquire immunotherapy developer Immune Design Inc. The per share price of $5.85 is a 293% premium to Immune Design’s market average in the ten days prior to the a...

Merck to buy late-stage immunotherapy firm Immune Design for $300m

As per terms of the deal, Merck’s subsidiary will pay $5.85 per share to purchase all outstanding shares of Immune Design. Immune Design has next-generation in vivo approaches, The post Merck to bu...

Merck to Acquire Immune Design for $300 Million

KENILWORTH, N.J. & SEATTLE & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Immune Design (NASDAQ:IMDZ), today...

Merck Acquires Immune Design for $300 Million in Cash

Shares of Immune Design are skyrocketing in premarket trading today after Merck announced it will acquire the Seattle-based oncology company for $300 million in cash. Immune Design stock has shot up m...

5 Top Weekly NASDAQ Biotech Stocks: Immune Design Soars

Immune Design, Zosano Pharma, Achieve Life Sciences, Insys Therapeutics and MediciNova were last week's top gainers. The post 5 Top Weekly NASDAQ Biotech Stocks: Immune Design Soars appeared first on ...

Merck agrees to acquire Immune Design for $300m

Merck has reached an agreement to acquire all outstanding shares of US-based late-stage immunotherapy firm Immune Design in an all...Read More... The post Merck agrees to acquire Immune Design for $30...

Merck To Buy Immune Design In $300 Mln Deal

KENILWORTH (NJ) (dpa-AFX) - Merck & Co Inc. (MRK) said that it agreed to buy Immune Design (IMDZ) for $5.85 per share in cash for an approximate value of $300 million.As per the terms of the acqui...

Merck in $300m Immune Design boost for Keytruda

Announced today, the deal sees Merck pay $5.85 per share to acquire Immune Design and its portfolio of late-stage immunotherapies.

PubMed Articles [2291 Associated PubMed Articles listed on BioPortfolio]

CORP: Partitional Calorimetry.

For thermal physiologists, calorimetry is an important methodological tool to assess human heat balance during heat or cold exposures. A whole-body direct calorimeter remains the gold standard instrum...

Immune checkpoint blockade and its combination therapy with small-molecule inhibitors for cancer treatment.

Initially understood for its physiological maintenance of self-tolerance, the immune checkpoint molecule has recently been recognized as a promising anti-cancer target. There has been considerable int...

Rational Design and In Vivo Characterization of Vaccine Adjuvants.

Many different adjuvants are currently being developed for subunit vaccines against a number of pathogens and diseases. Rational design is increasingly used to develop novel vaccine adjuvants, which r...

Exploring the impact of inoculum dose on host immunity and morbidity to inform model-based vaccine design.

Vaccination is an effective method to protect against infectious diseases. An important consideration in any vaccine formulation is the inoculum dose, i.e., amount of antigen or live attenuated pathog...

Immune correlates of protection from West Nile virus neuroinvasion and disease.

A challenge to the design of improved therapeutics and prevention strategies for neuroinvasive infection and associated disease is the lack of known natural immune correlates of protection. A relevant...

Clinical Trials [4402 Associated Clinical Trials listed on BioPortfolio]

Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults

The purpose of this study is to evaluate the body's immune response at different time points to an FDA-approved seasonal influenza vaccine. By better understanding the way the immune syste...

Immune Response to Cytomegalovirus

This study will evaluate immune responses against cytomegalovirus (CMV). About 80 percent of adults have been exposed to this virus. CMV typically remains dormant (inactive) in the body, c...

Effect of Fasting and Refeeding on T-cell Fate

Background: Researchers want to better understand the body s immune response to calorie restriction. To do this, they are asking healthy volunteers to fast for 24 hours. Researchers will ...

Mechanisms of Immune Deficiency

1. The purpose of this study is to learn more about the changes in genes, cells and proteins that cause immune deficiency diseases. 2. The early stages of the study will focus on t...

Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules

The ex-vivo lung will be evaluated by XLTF-UC180 for localization of the tumor. The ultrasound probe will be put on the lung surface in several different directions to obtain the cross sec...

Companies [1466 Associated Companies listed on BioPortfolio]

Immune Design Corp.

Immune Design is a clinical-stage immunotherapy company employing next-generation in vivo approaches to enable the body’s immune system to fight disease. The company’s t...

World of Health Biotech Co.Ltd

Anti HBV Specific Active Immunotherapy (Anti HBV Therapeutic Vaccine) using recombinant hepatitis B vaccine (standard HBV vaccine) as an immunogenic specific antigen and several cytokines as an immune...

Progenitor Life Sciences LLC

Progenitor Life Sciences provides unique and proprietary technologies to the rapidly growing immune oncology CAR-T development marketplace. The company is addressing key needs usi...

Immune-Onc Therapeutics, Inc.

Immune-Onc Therapeutics, Inc. (“Immune-Onc”) is a newly established biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatmen...

NORLOFF COMPUTER CORP

Nil

More Information about "Immune Design Corp." on BioPortfolio

We have published hundreds of Immune Design Corp. news stories on BioPortfolio along with dozens of Immune Design Corp. Clinical Trials and PubMed Articles about Immune Design Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Immune Design Corp. Companies in our database. You can also find out about relevant Immune Design Corp. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record